-
Diagnosis and Therapeutic Consensus: Taking a Stand on Neuromuscular Disease
-
Advances in Multiple Sclerosis Therapy: Highlights From ECTRIMS 2009
-
The Importance of Registries in the Study of AF-Related Stroke
-
Tackling the Challenges and Consequences of Pain: New Thinking, New Choices
-
Managing Progressive Multiple Sclerosis: Addressing Challenges in Diagnosis and Treatment
-
Clinical Decision-Making in Multiple Sclerosis
-
Treatment Decisions in Major Depressive Disorder: Choosing an Augmentation Strategy
-
New Developments in Aesthetic Therapy With Botulinum Neurotoxin A
-
Combination Therapy and Cardiovascular Events: A Neurologist's Perspective
-
Oral and Parenteral Therapies for Multiple Sclerosis: Stratifying the Risks and Benefits
-
Novel Treatments and Imaging in Multiple Sclerosis
-
The Current State of Care for Alzheimer's Disease: What We Know, What We Don't Know, and Opinions About Best Practices
Special Collection
Not Certified for Credit
Medical Education Content
- Neuroprotection and Glaucoma
- Neuro-Oncology Learning Portfolio: An Update on Glioblastoma
- 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
- Outcomes Measures, New Disease-Modifying Therapies, and Assessing Neurodegeneration in Multiple Sclerosis -- An Expert Interview With Ludwig Kappos, MD
- Insomnia and Anxiety Complicated By Substance Abuse: Management and Treatment Options
Advisory Board
- Robert J. Adams, MD, MS, FAHA
- Mark J. Alberts, MD
- Neil A. Busis, MD
- Lawrence W. Elmer, MD, PhD
- Randolph W. Evans, MD
- Samuel E. Gandy, MD, PhD
- Robert C. Green, MD, MPH
- Werner Hacke, MD, PhD
- Andres M. Kanner, MD
- Jan Paul Muizelaar MD, PhD
- Russell K. Portenoy, MD
- Thomas Roth, PhD
- Randall T. Schapiro, MD
- Kapil D. Sethi, MD
- Stephen D. Silberstein, MD
- Michael J. Thorpy, MB, ChB
Scientific Director